Nazzal S - Search Results

1

Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications.

Darweesh RS, Ayoub NM, Nazzal S. Darweesh RS, et al. Among authors: nazzal s. Int J Nanomedicine. 2019 Sep 19;14:7643-7663. doi: 10.2147/IJN.S223941. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31571869 Free PMC article. Review.

2

Entrapment into nanoemulsions potentiates the anticancer activity of tocotrienols against the highly malignant (+SA) mouse mammary epithelial cells.

Alayoubi A, Ayoub NM, Malaviya A, Sylvester PW, Nazzal S. Alayoubi A, et al. Among authors: nazzal s. J Nanosci Nanotechnol. 2014 May;14(5):4002-5. doi: 10.1166/jnn.2014.8843. J Nanosci Nanotechnol. 2014. PMID: 24734680

3

Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems.

Kamal MM, Akter S, Lin CN, Nazzal S. Kamal MM, et al. Among authors: nazzal s. Arch Pharm Res. 2020 Apr;43(4):371-384. doi: 10.1007/s12272-020-01225-2. Epub 2020 Mar 10. Arch Pharm Res. 2020. PMID: 32152852 Review.

4

Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation.

Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. Nazzal S, et al. Int J Pharm. 2002 Mar 20;235(1-2):247-65. doi: 10.1016/s0378-5173(02)00003-0. Int J Pharm. 2002. PMID: 11879759

5

Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients.

Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Nazzal S, et al. Int J Pharm. 2002 Jun 20;240(1-2):103-14. doi: 10.1016/s0378-5173(02)00130-8. Int J Pharm. 2002. PMID: 12062506

6

Preparation, characterization, and anticancer effects of simvastatin-tocotrienol lipid nanoparticles.

Ali H, Shirode AB, Sylvester PW, Nazzal S. Ali H, et al. Among authors: nazzal s. Int J Pharm. 2010 Apr 15;389(1-2):223-31. doi: 10.1016/j.ijpharm.2010.01.018. Epub 2010 Feb 1. Int J Pharm. 2010. PMID: 20123009

7

Novel sulforaphane-enabled self-microemulsifying delivery systems (SFN-SMEDDS) of taxanes: Formulation development and in vitro cytotoxicity against breast cancer cells.

Kamal MM, Nazzal S. Kamal MM, et al. Among authors: nazzal s. Int J Pharm. 2018 Jan 30;536(1):187-198. doi: 10.1016/j.ijpharm.2017.11.063. Epub 2017 Nov 28. Int J Pharm. 2018. PMID: 29195916

8

Novel olive oil phenolic (-)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities.

Qusa MH, Siddique AB, Nazzal S, El Sayed KA. Qusa MH, et al. Among authors: nazzal s. Int J Pharm. 2019 Oct 5;569:118596. doi: 10.1016/j.ijpharm.2019.118596. Epub 2019 Aug 5. Int J Pharm. 2019. PMID: 31394181 Free PMC article.

9

AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for development of cancer therapeutics.

Elsanhoury R, Alasmari A, Parupathi P, Jumaa M, Al-Fayoumi S, Kumar A, Khashan R, Nazzal S, Fayyad AA. Elsanhoury R, et al. Among authors: nazzal s. Int J Pharm. 2023 Oct 15;645:123384. doi: 10.1016/j.ijpharm.2023.123384. Epub 2023 Sep 8. Int J Pharm. 2023. PMID: 37678472

10

Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: evidence studies by Differential Scanning Calorimetry (DSC) and Proton Nuclear Magnetic Resonance spectroscopy ((1)H NMR).

Ali H, El-Sayed K, Sylvester PW, Nazzal S. Ali H, et al. Among authors: nazzal s. Colloids Surf B Biointerfaces. 2010 Jun 1;77(2):286-97. doi: 10.1016/j.colsurfb.2010.02.003. Epub 2010 Feb 11. Colloids Surf B Biointerfaces. 2010. PMID: 20189780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page